Clinical trial
Use of a Mobile Brain-Body Imaging Approach to Evaluate the Effects of Rhythmic Auditory Stimulation on Gait and Brain Function in Alzheimer's Disease
NCT07659964 is registered in ClinicalTrials.gov with Boston University Charles River Campus as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Use of a Mobile Brain-Body Imaging Approach to Evaluate the Effects of Rhythmic Auditory Stimulation on Gait and Brain Function in Alzheimer's Disease
- Lead sponsor
- Boston University Charles River Campus
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- June 1, 2026
- Completion date
- December 31, 2026
- Enrollment
- 40 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
alzheimer disease (ad), mild cognitive impairment (mci)